Pain Treatments Less Effective for those with Irritable Bowel
Tuesday, 19 August, 2014
Researchers have discovered Ìýthe immune system is defective inÌýpeople suffering from irritable bowel syndrome, which is a major reason why sufferersÌýhave ongoing issues with pain.
TheÌýresearch from theÌýUniversityÌýof Adelaide isÌýthe first of its kind in the world and could also explain whyÌýsome painkillers may not offer satisfactory relief to sufferers.
IrritableÌýbowel syndrome (IBS) affects up to 10 per cent of the community. There are different forms of IBSÌýbut all of them involve unexplained gut pain, which often has the greatestÌýimpact on sufferers' quality of life.
ScientistsÌýin the University's Nerve-Gut Research Laboratory have now demonstrated theÌýmechanisms involved, and the differences between the immune pain response inÌýhealthy people and those suffering from IBS. The results of their work have been published in the journalÌýBrain,ÌýBehavior, and Immunity.
"ThisÌýstudy is the first to give us a real understanding of the interaction betweenÌýthe immune system and pain symptoms in IBS patients," says lead author DrÌýPatrick Hughes, NHMRC Peter Doherty Fellow with the University's School of Medicine.
"TheÌýgut contains specialised immune cells, known as monocytes and macrophages. Our research has shown that in healthyÌýpeople, these immune cells normally secrete opioid chemicals,Ìýlike morphine, that block pain. But inÌýpeople with IBS, the opioid production by these cells is defective," heÌýsays.
"SoÌýit's no wonder that people with IBS are experiencing ongoing periods ofÌýunexplained pain. And if the immuneÌýsystem is defective, it may also mean that painkilling medications taken by theÌýpatient to relieve their symptoms are not being adequately converted to pain
relief."
TheÌýresearch, upported by the National Health and Medical Research CouncilÌý(NHMRC),Ìýinvolved samples from more than 100 people, half of them healthy andÌýhalf suffering from IBS.
DrÌýHughes says theÌýexact cause of pain in IBS sufferers remains unknown, "but we have nowÌýconfirmed, and detailed, information about the important role of the immuneÌýsystem in this pain response".
"It'sÌýour hope that this work could eventually lead to more targeted treatments forÌýIBS sufferers, to help treat or prevent the long-term pain theyÌýexperience," he says.
Ìý
Victoria's Q3 median ED wait times the lowest on record
Victoria's quarter three performance data (January–March) has shown improvement across...
Irregularities in a clinician's cases prompt 15-month lookback
St Vincent's ºÚÁϳԹÏÈºÍø Sydney has detailed a 15-month lookback review — prompted by...
Two researchers receive $899,000 in cardiovascular funding
In heart-related news this Heart Week (5–11 May), two University of Newcastle researchers...